Eficacia de una crema lipolítica en un tratamiento de sobrepeso y obesidad

dc.contributor.authorKalmar, Isaac
dc.contributor.authorCortés-Castell, Ernesto
dc.contributor.authorRizo-Baeza, Mercedes
dc.contributor.authorConsuegra, José Rafael
dc.contributor.authorJiménez-Cabas, Javier
dc.description.abstractObjetivo. Evaluar la eficacia coadyuvante de una combinación de ingredientes cosméticos en forma de crema lipolítica con dieta hipocalórica y actividad física comparada con dieta hipocalórica y actividad física para el tratamiento del sobrepeso y la obesidad en pacientes. Material y métodos. Se realizó un estudio monocéntrico, abierto y aleatorizado de grupos paralelos de 102 pacientes que consultaron a un centro de nutrición médico-clínico para el tratamiento del sobrepeso y la obesidad. Los perímetros de altura, brazo, cintura, cadera y muslo y el análisis de la composición corporal segmentaria con un equipo de impedancia se estudiaron en pacientes de 18 a 99 años de ambos sexos con asistencia voluntaria y con presencia de sobrepeso u obesidad durante un período de 16 semanas consecutivas. Los datos se analizaron estadísticamente comparando los valores iniciales y finales de todos los valores en ambos grupos. La seguridad fue monitoreada por la incidencia de eventos adversos. Un valor de p<0,001 fue considerado como de significación estadística. Resultados. Del total de 102 pacientes, se aplicaron los criterios de inclusión y exclusión; se incluyeron y analizaron 45 y 47 casos, respectivamente. La edad oscila entre 39,16 y 42,09 años (p = 0,246); el peso inicial 85,9 kg vs 85,08 kg (p = 0,810); perímetros: cintura inicial de 100,4 cm frente a 99,7 cm (p = 0,826); brazo inicial de 32,9 cm vs 33,4 cm (p = 0,453); cadera inicial: 108,6cm vs 107,7 (p = 0,666). Peso final 82,6 kg vs 78,7 kg (p = 0,227); perímetros: cintura final de 94,9 cm frente a 90,9 cm (p = 0,144); brazo final de 31,8 cm frente a 31,4 cm (p = 0,453); Cadera final: 106,7 cm vs 102,1 (p = 0,074). No hubo ningún informe de efectos secundarios no deseados con el uso de crema lipolítica, presentando una buena aceptabilidad. Los pacientes con crema lipolítica como adyuvante en el tratamiento del sobrepeso u obesidad perdieron mayor IMC, mayor porcentaje de peso y mayor porcentaje de grasa (p<0,001).spa
dc.description.abstractObjective. To evaluate the coadyouvant efficacy of a combination of cosmetics ingredients in the form of a lipolytic cream with hypocaloric diet and physical activity and compared with hypocaloric diet and physical activity for overweight and obesity treatment in patients. Material and methods. It was conducted a monocentric, open-label, randomized study of parallel groups of 102 patients that consulted in a medical-clinical nutrition center for overweight and obesity treatment. Height, arm, waist, hip and thigh perimeters and the analysis of segmental body composition with an impedance team were studied in patients between 18 and 99 years, of both sexes with voluntary attendance and with presence of overweight or obesity during a period of 16 consecutive weeks. The data were statistically analyzed by comparing the initial and final values of all the values in both groups. Safety was monitored by the incidence of adverse events. A value of p<0.001 was considered as statistical significance. Results. Of the total of 102 patients, the inclusion and exclusion criteria were applied; 45 and 47 cases are included and analyzed respectively. The age ranges between 39.16 vs 42.09 years (p = 0.246); initial weight 85.9 kg vs 85.08 kg (p = 0.810); perimeters: initial waist of 100.4cm vs 99.7cm (p = 0.826); initial arm of 32.9cm vs 33.4cm (p = 0.453); initial hip: 108.6cm vs 107.7 (p = 0.666). Final weight 82.6 kg vs 78.7 kg (p = 0.227); perimeters: final waist of 94.9 cm vs 90.9 cm (p = 0.144); final arm of 31.8 cm vs 31.4 cm (p = 0.453); final hip: 106.7 cm vs 102, 1 (p = 0.074). There was no report of unwanted side effects with the use of lipolytic cream, presented good acceptability. Patients with lipolytic cream as adjuvant in the treatment of overweight or obesity lose greater BMI, greater percentage of weight and greater percentage of fat (p <0.001). Conclusion. Patients with lipolytic cream as adjuvant in the treatment of overweight or obesity lose greater BMI, greater percentage of weight and greater percentage of fat.eng
dc.publisherSociedad Venezolana de Farmacología Clínica y Terapéuticaspa
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.sourceRevista AVFT-Archivos Venezolanos de Farmacología y Terapéuticaspa
dc.sourceVol. 38 No. 2 (2019)spa
dc.source.bibliographicCitationWHO. Global Strategy on Diet, Physical Activity and Health: Childhood overweight and obesity. Available at: https://www.who.int/dietphysicalactivity/ childhood/en/ Accessed on: 18.03.2019eng
dc.source.bibliographicCitationKuzmar I, Rizo M, Cortés-Castell E. 2014. Adherence to an overweight and obesity treatment: how to motivate a patient? Peer J 2:e495 https://doi.org/10.7717/peerj.495eng
dc.source.bibliographicCitationGreenway FL, Bray GA, Heber D. Topical fat reduction. Obes Res. 1995;3(4):561‐568.eng
dc.source.bibliographicCitationEscalante G, Bryan P, Rodriguez J. Effects of a topical lotion containing aminophylline, caffeine, yohimbe, l‐carnitine, and gotu kola on thigh circumference,skinfold thickness, and fat mass in sedentary females. J Cosmet Dermatol. 2018;00:1–7. https://doi.org/10.1111/ jocd.12801eng
dc.source.bibliographicCitationInvima. Guía de definiciones de formas farmacéuticas. 2015: 1-11. Available at: https://www.invima.gov.co/procesos/archivos/ASS/ RSA/ASS-RSA-GU005.pdf Accessed on: 18.03.2019spa
dc.source.bibliographicCitationTejedor C. Tema 18: Lipólisis y oxidación de ácidos grasos. Available at: http://www3.uah.es/bioquimica/Tejedor/BBM-II_farmacia/ T9-Lipolisis.pdf Accessed on: 18.03.2019spa
dc.source.bibliographicCitationDuncan R, Ahmadian M, Jaworski K, Sarkadi-Nagy E, and Sook- Sul H. Regulation of Lipolysis in Adipocytes. Annu Rev Nutr. 2007;27:79–101. DOI:10.1146/annurev.nutr.27.061406.093734.eng
dc.source.bibliographicCitationRoure R, Oddos T, Rossi A, Vial F, Bertin C. Evaluation of the efficacy of a topical cosmetic slimming product combining tetrahydroxypro‐ pyl ethylenediamine, caffeine, carnitine, forskolin and retinol, in vitro, ex vivo and in vivo studies. Int J Cosmet Sci. 2011;33:519‐526.eng
dc.source.bibliographicCitationChih-Hsing W, Feng-Hwa L, Chin-Song C, Tsui-Chen C, Ru-Hsueh W and Chih-Jen C. Relationship among habitual teaconsumption, percent body fat, and body fat distribution. Obes Res. 2003;11:1088 –1095.eng
dc.source.bibliographicCitationAcheson K, Zahorska‐Markiewicz B, Pittet P, Anantharaman K, Jequier E. Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals. Am J Clin Nutr. 1980;33(5):989‐997. DOI: 10.1093/ajcn/33.5.989eng
dc.source.bibliographicCitationHaller CA, Jacob P, Benowitz NL. Enhanced stimulant and metabolic effects of ephedrine and caffeine. Clin Pharmacol Ther. 2004;75:259‐273. DOI: 10.1016/j.clpt.2003.11.375eng
dc.source.bibliographicCitationTouitou E, Godin B, & Weiss C. Enhanced delivery of drugs into and across the skin by ethosomal carriers. Drug Development Research, 2000;50(3-4): 406–415. DOI: 10.1002/1098-2299(200007/08)50:3/4<406::aid-ddr23> 3.0.co;2-meng
dc.source.bibliographicCitationDiepvens K, Westerterp KR & Westerterp-Plantenga MS. Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007;92(1):R77– R85. DOI: 10.1152/ajpregu. 00832.2005eng
dc.source.bibliographicCitationHerman A., & Herman AP. (2013). Caffeine’s Mechanisms of Action and Its Cosmetic Use. Skin Pharmacology and Physiology, 2013;26(1):8–14. DOI: 10.1159/000343174eng
dc.source.bibliographicCitationRibas GS, Vargas CR & Wajner M. l-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders. Gene, 2014;533(2):469–476. DOI:10.1016/j.gene.2013.10.017eng
dc.source.bibliographicCitationCha Youn-Soo. Effects of L-carnitine on obesity, diabetes, and as anergogenic aid. Asia Pac J Clin Nutr 2008;17(S1):306-308eng
dc.source.bibliographicCitationDecsi T, Molnár D & Koletzko B. Reduced plasma concentrations of alpha- tocopherol and beta-carotene in obese boys. The Journal of Pediatrics, 1997;130(4):653–655. DOI: 10.1016/s0022- 3476(97)70253-1eng
dc.source.bibliographicCitationWei, F., Qu, C., Song, T., Ding, G., Fan, Z., Liu, D., … Wang, S. Vitamin C treatment promotes mesenchymal stem cell sheet formation and tissue regeneration by elevating telomerase activity. Journal of Cellular Physiology, 2012;227(9):3216–3224. doi:10.1002/ jcp.24012eng
dc.source.bibliographicCitationRupérez, P., Ahrazem, O., & Leal, J. A. Potential Antioxidant Capacity of Sulfated Polysaccharides from the Edible Marine Brown SeaweedFucus vesiculosus. Journal of Agricultural and Food Chemistry, 2002;50(4):840–845. doi:10.1021/jf010908oeng
dc.source.bibliographicCitationChandrika, U. G., & Prasad Kumara, P. A. A. S. Gotu Kola (Centella asiatica). Advances in Food and Nutrition Research, 2015:125–157. doi:10.1016/bs.afnr.2015.08.001eng
dc.source.bibliographicCitationSharangi, A. B. Medicinal and therapeutic potentialities of tea (Camellia sinensis L.) – A review. Food Research International, 2009; 42(5-6): 529–535. doi:10.1016/j.foodres.2009.01.007eng
dc.source.bibliographicCitationKuzmar, I; Cortés, E & Rizo, M. Attendance and response to treatment for overweight and obesity in a Barranquilla (Colombia) population. Nutr. clín. diet. hosp. 2014; 34(3):20-28 DOI: 10.12873/343kuzmareng
dc.source.bibliographicCitationKuzmar, I et al. Hábitos y estado nutricional relacionados con las diferentes carreras universitarias. Archivos Venezolanos de Farmacología y Terapéutica, 2018; 37 (3): 275-282spa
dc.source.bibliographicCitationCollis N, Elliot LA, Sharpe C, Sharpe DT. Cellulite treatment: a myth or reality: a prospective randomized, controlled trial of two therapies, endermologie and aminophylline cream. Plastic and Reconstructive Surgery, 1999; 104(4):1110- 1114 DOI: 10.1097/00006534- 199909040-00034.eng
dc.subjectCrema para la pielspa
dc.subjectSkin creameng
dc.titleEficacia de una crema lipolítica en un tratamiento de sobrepeso y obesidadspa
dc.title.alternativeEfficacy of a lipolytic cream in an overweight and obesity treatmenteng


Bloque original
Mostrando 1 - 1 de 1
545.73 KB
Adobe Portable Document Format
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
381 B
Item-specific license agreed upon to submission